A.L. Børresen-Dale

3.4k total citations · 1 hit paper
41 papers, 2.4k citations indexed

About

A.L. Børresen-Dale is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, A.L. Børresen-Dale has authored 41 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in A.L. Børresen-Dale's work include Cancer Genomics and Diagnostics (11 papers), Cancer-related Molecular Pathways (10 papers) and Gene expression and cancer classification (7 papers). A.L. Børresen-Dale is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Cancer-related Molecular Pathways (10 papers) and Gene expression and cancer classification (7 papers). A.L. Børresen-Dale collaborates with scholars based in Norway, United States and Sweden. A.L. Børresen-Dale's co-authors include Pierre Hainaut, Magali Olivier, Maria Isabel Achatz, Audrey Petitjean, Charles M. Perou, Rolf Kåresen, I. K. Bukholm, Jahn M. Nesland, Olli Kallioniemi and Ragnhild A. Lothe and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

A.L. Børresen-Dale

41 papers receiving 2.4k citations

Hit Papers

TP53 mutations in human cancers: functional selection and... 2007 2026 2013 2019 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
    2007 689 citations Audrey Petitjean, Maria Isabel Achatz et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.L. Børresen-Dale Norway 20 1.5k 970 762 352 339 41 2.4k
F. Spyratos France 23 906 0.6× 1.0k 1.0× 796 1.0× 290 0.8× 389 1.1× 52 2.0k
Steven McKinney Canada 18 1.2k 0.8× 1.2k 1.2× 977 1.3× 346 1.0× 374 1.1× 30 2.9k
J. Teague United Kingdom 6 1.4k 0.9× 458 0.5× 623 0.8× 246 0.7× 449 1.3× 7 2.0k
Stefania Tommasi Italy 28 1.5k 1.0× 828 0.9× 846 1.1× 267 0.8× 688 2.0× 139 2.7k
Maurice P.H.M. Jansen Netherlands 26 1.3k 0.9× 806 0.8× 1.1k 1.5× 265 0.8× 361 1.1× 66 2.2k
Catherine A. Schnabel United States 26 1.2k 0.8× 1.1k 1.1× 1.2k 1.6× 363 1.0× 640 1.9× 103 2.8k
Diana Mandelker United States 23 1.3k 0.9× 867 0.9× 718 0.9× 388 1.1× 311 0.9× 94 2.5k
Melora D. Berardo United States 8 811 0.6× 1.3k 1.3× 962 1.3× 364 1.0× 509 1.5× 10 2.4k
Elizabeth Mambo United States 25 2.5k 1.7× 757 0.8× 983 1.3× 345 1.0× 311 0.9× 29 3.6k
Shunzo Kobayashi Japan 28 1.1k 0.8× 1.2k 1.2× 786 1.0× 237 0.7× 716 2.1× 74 2.3k

Countries citing papers authored by A.L. Børresen-Dale

Since Specialization
Citations

This map shows the geographic impact of A.L. Børresen-Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Børresen-Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Børresen-Dale more than expected).

Fields of papers citing papers by A.L. Børresen-Dale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.L. Børresen-Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Børresen-Dale. The network helps show where A.L. Børresen-Dale may publish in the future.

Co-authorship network of co-authors of A.L. Børresen-Dale

This figure shows the co-authorship network connecting the top 25 collaborators of A.L. Børresen-Dale. A scholar is included among the top collaborators of A.L. Børresen-Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.L. Børresen-Dale. A.L. Børresen-Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lothe, Inger Marie Bowitz, Knut Jørgen Labori, Julian Hamfjord, et al.. (2015). Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma. Molecular Oncology. 10(2). 303–316. 15 indexed citations
2.
Fleischer, Thomas, Arnoldo Frigessi, Kevin C. Johnson, et al.. (2014). Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome biology. 15(8). 435–435. 139 indexed citations
3.
Aure, Miriam R. R., Israel Steinfeld, Lars O. Baumbusch, et al.. (2013). Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data. PLoS ONE. 8(1). e53014–e53014. 43 indexed citations
4.
Joshi, Himanshu, Silje Nord, Arnoldo Frigessi, A.L. Børresen-Dale, & Vessela N. Kristensen. (2012). Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes. BMC Genomics. 13(1). 199–199. 14 indexed citations
5.
Hongisto, Vesa, Kristine Kleivi Sahlberg, Henrik Edgren, et al.. (2012). 338 The HER2 Amplicon Includes Several Genes Required for the Growth and Survival of HER2 Positive Breast Cancer Cells. European Journal of Cancer. 48. S82–S83. 1 indexed citations
6.
Edgren, Henrik, Astrid Murumägi, Sara Kangaspeska, et al.. (2011). Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome biology. 12(1). R6–R6. 226 indexed citations
7.
Zhao, Xi, Einar Andreas Rødland, Thérese Sørlie, et al.. (2011). Combining Gene Signatures Improves Prediction of Breast Cancer Survival. PLoS ONE. 6(3). e17845–e17845. 33 indexed citations
8.
Holstege, Henne, Hugo M. Horlings, Arno Velds, et al.. (2010). BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations. BMC Cancer. 10(1). 654–654. 43 indexed citations
9.
Perou, Charles M. & A.L. Børresen-Dale. (2010). Systems Biology and Genomics of Breast Cancer. Cold Spring Harbor Perspectives in Biology. 3(2). a003293–a003293. 180 indexed citations
10.
Myhre, Simen, Trine Tramm, Jan Alsner, et al.. (2010). In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome. PLoS ONE. 5(11). e14002–e14002. 19 indexed citations
11.
Loge, J.H., et al.. (2009). Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. The Pharmacogenomics Journal. 9(5). 333–340. 38 indexed citations
12.
13.
Petitjean, Audrey, Maria Isabel Achatz, A.L. Børresen-Dale, Pierre Hainaut, & Magali Olivier. (2007). TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 26(15). 2157–2165. 689 indexed citations breakdown →
14.
Stray‐Pedersen, Asbjørg, et al.. (2007). Alpha fetoprotein is increasing with age in ataxia–telangiectasia. European Journal of Paediatric Neurology. 11(6). 375–380. 75 indexed citations
15.
Olsen, Jørgen H., Johanne M D Hahnemann, A.L. Børresen-Dale, et al.. (2001). Cancer in Patients With Ataxia-Telangiectasia and in Their Relatives in the Nordic Countries. JNCI Journal of the National Cancer Institute. 93(2). 121–127. 169 indexed citations
16.
Andersen, T I, Björn Erikstein, Rolf Kåresen, et al.. (2000). Screening breast cancer patients for Norwegian ATM mutations. British Journal of Cancer. 83(12). 1650–1653. 9 indexed citations
17.
Skomedal, Hanne, Åslaug Helland, Gunnar B. Kristensen, R Holm, & A.L. Børresen-Dale. (1999). Allelic imbalance at chromosome region 11q23 in cervical carcinomas. European Journal of Cancer. 35(4). 659–663. 8 indexed citations
18.
Kressner, Ulf, Jens Bjørheim, Siobhan Wahlberg, et al.. (1998). Ki-ras mutations and prognosis in colorectal cancer. European Journal of Cancer. 34(4). 518–521. 63 indexed citations
19.
Ellis, PA, Per Eystein Lønning, A.L. Børresen-Dale, et al.. (1997). Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. British Journal of Cancer. 76(4). 480–485. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Spyratos Breakdown of academic impact, for papers by Steven McKinney Breakdown of academic impact, for papers by J. Teague Breakdown of academic impact, for papers by Stefania Tommasi Breakdown of academic impact, for papers by Maurice P.H.M. Jansen Breakdown of academic impact, for papers by Catherine A. Schnabel Breakdown of academic impact, for papers by Diana Mandelker Breakdown of academic impact, for papers by Melora D. Berardo Breakdown of academic impact, for papers by Elizabeth Mambo Breakdown of academic impact, for papers by Shunzo Kobayashi
Rankless by CCL
2026